ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $13,000 | +550.0% | 1,100 | +1000.0% | 0.00% | – |
| Q2 2018 | $2,000 | -99.1% | 100 | -99.4% | 0.00% | -100.0% |
| Q1 2018 | $211,000 | +7.7% | 17,400 | +1.8% | 0.05% | +18.2% |
| Q4 2017 | $196,000 | -22.2% | 17,100 | -17.0% | 0.04% | -21.4% |
| Q3 2017 | $252,000 | -57.1% | 20,600 | -59.8% | 0.06% | -34.9% |
| Q2 2017 | $587,000 | +46.4% | 51,300 | +165.8% | 0.09% | +87.0% |
| Q1 2017 | $401,000 | +1385.2% | 19,300 | +1384.6% | 0.05% | +1433.3% |
| Q4 2016 | $27,000 | -90.2% | 1,300 | -84.5% | 0.00% | -91.4% |
| Q3 2016 | $275,000 | – | 8,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |